在中国人口中获得结直肠癌查,2020年:以覆盖面为重点的综合分析分析
Yan-Jie Li1, Xin Wang1, Yu-Jie Wu1
1Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
International journal of cancer
|March 30, 2024
概括
中国的结肠直肠癌 (CRC) 查覆盖率仍然很低,有组织的计划在2020年仅达到目标人口的2.7%. 进一步努力至关重要,以加强CRC查的准入,并提高早期检测率.
科学领域:
- 公共卫生 公共卫生
- 癌症流行病学 癌症流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 结肠直肠癌 (CRC) 查对于早期检测和改善结果至关重要.
- 中国现有的CRC查方法包括有组织的计划,机会性查和体检.
- 量化精确的查覆盖率是一个重大挑战.
研究的目的:
- 量化中国结直肠癌查覆盖率.
- 估计不同CRC查方式的覆盖率.
- 确定CRC查准入方面的差距和需要改进的领域.
主要方法:
- 采用快速审查方法,使用来自发表文章,官方网站和计划报告的数据.
- 通过分析每个查类型的文章数量和中位数样本大小来量化覆盖率.
- 分析包括到2020年启动的有组织查计划.
主要成果:
- 2020年,中国有组织的CRC查计划 (40-74岁) 的估计覆盖率为2.7%.
- 组织计划的累计覆盖率为5.3% (2年) 和7.7% (3年).
- 包括所有方法在内的CRC查覆盖率在2020年为40-74岁的人群中为3.0%.
结论:
- 目前,中国的结肠直肠癌 (CRC) 查覆盖率很低,需要加强公共卫生干预.
- 有限证据表明机会性CRC查和体检访问,需要进一步的定量研究.
- 需要显著改善人口对CRC查的准入,以减少结直肠癌的负担.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345


